![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » DRUG STOCKS SLIP; DISCOVERY PLUNGES ON DRUG DELAY
DRUG STOCKS SLIP; DISCOVERY PLUNGES ON DRUG DELAY
April 5, 2006
Drug stocks slipped into negative territory early Wednesday as Discovery Laboratories plunged on news that the FDA still won't approve its pediatric treatment Surfaxin.
Investors
Business Daily
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct